HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹52 Cr | ₹49 Cr | ₹35 Cr | ₹30 Cr | ₹30 Cr |
What is the latest Contingent Liabilities ratio of HIKAL ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹52 Cr |
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹30 Cr |
How is Contingent Liabilities of HIKAL Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹52 Cr | 6.75 | |
| Mar2024 | ₹49 Cr | 41.17 | |
| Mar2023 | ₹35 Cr | 17.23 | |
| Mar2022 | ₹30 Cr | 0.00 | |
| Mar2021 | ₹30 Cr | - | |
Compare Contingent Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,684.9 Cr | -0.4% | 14.8% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.4% |
14.8% |
-38.8% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses